News

The China-ASEAN Regional Medical Products Trading Platform finalized its inaugural 2026 transaction worth over 10 million yuan between Qilu Pharmaceutical and a Thai buyer, enhancing cross-border pharma trade.

The EMA Management Board confirmed the near-complete setup of governance structures for new EU pharmaceutical legislation implementation and outlined a roadmap for mandatory electronic product information.

Hong Kong solidifies its role as a key financial center for Chinese biotech firms, enabling repeat capital raises and IPOs amid surging global deal flows.

EU co-legislators have finalized a provisional deal on the pharmaceutical reform package, modernizing regulations for the first time in 20 years to enhance medicine availability, affordability, innovation, and supply chain resilience across Europe.

Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and includes its subsidiaries and/or associated companies) announced that the US Food and Drug Administration

Japan recorded the highest number of US FDA novel-drug approvals among Asian markets from 2015-2023, driven by robust regulatory frameworks and global integration, according to McKinsey.

The EMA Management Board confirmed the governance structure for new EU pharmaceutical legislation is largely in place, alongside adoption of the 2025 annual report and preparations for electronic product information rollout.

Zuellig Pharma has secured rights to distribute Eli Lilly's Cialis (tadalafil) in three more Asian markets, strengthening its pharmaceutical distribution network and supply chain capabilities.

The European Medicines Agency has launched an open call for large pharmaceutical companies to apply for portfolio and technology meetings scheduled for the second half of 2026, aimed at addressing development challenges and innovative technologies.

The European Parliament has adopted proposals for the Critical Medicines Act, prioritizing EU manufacturing investments and cross-border procurement to enhance pharmaceutical supply chain resilience.